MoonLake Immunotherapeutics
MLTX
#5937
Rank
HK$7.85 B
Marketcap
HK$110.87
Share price
-5.44%
Change (1 day)
-72.98%
Change (1 year)

Earnings for MoonLake Immunotherapeutics (MLTX)

Earnings in 2025 (TTM): -HK$1.65 Billion

According to MoonLake Immunotherapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -HK$1.03 Billion a decrease over its 2023 earnings that were of -HK$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MoonLake Immunotherapeutics from 2022 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$1.65 Billion61.23%
2024 -HK$1.03 Billion142.55%
2023 -HK$0.43 Billion-16.81%
2022 -HK$0.51 Billion